Apotex Health Corp saw a notable gain in its stock price during yesterday's trading session.
In the latest trading session, Apotex Health Corp (APTX.TO) experienced a positive shift, closing up by 2.53%. This upward movement reflects investor confidence and potential growth in the company's future prospects.
Advertisement
Apotex Health Corp
APTX.TO
APTX.TO
Apotex Health Corp
WealthAwesomeMarket cap
$7.28B
52W high
$40.11
52W low
$26.01
1W change
+5.21%
Analyst Price Targets
Based on analyst covering APTX · as of Sep 23, 2026
Wall Street analysts forecast APTX stock price to rise 27.3% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$41.37
+27.3% Upside
Previously C$41.23 on Sep 17, 2026
Current Price
C$32.50
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on APTX's historical volatility
30-Day Vol
45.6%
Annualized
90-Day Vol
46.5%
Annualized
Trend (90d)
-41.7%
Annualized drift
90d Mean
C$28.00
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$30.93 | C$26.42 – C$36.20 |
| 60 trading days | C$29.43 | C$23.56 – C$36.77 |
| 90 trading days | C$28.00 | C$21.32 – C$36.78 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: The recent increase in Apotex's stock price may indicate a favorable outlook for the company, especially as it continues to expand its operations and product offerings.
Apotex Health Corp Market Cap Reaches CA$7.24 Billion
With a market cap of CA$7.24 billion, Apotex Health Corp continues to position itself as a significant player in the pharmaceutical sector.
Bull case
Apotex's recent financial results show promising revenue growth. The company’s strategic initiatives, including a recent offering of senior unsecured notes, could strengthen its financial position and enhance its presence in the market.
Bear case
Despite the recent gain, Apotex's profit margin is still negative, raising concerns about its long-term profitability and sustainability in a competitive market.
Recent Performance Overview
Advertisement
Apotex Health Corp's stock price increased by 2.53% in yesterday's session, closing at CA$32.47. This gain comes amidst a backdrop of strategic initiatives aimed at enhancing the company's market position.
Financial Insights
With a market cap of CA$7.24 billion, Apotex is navigating a challenging market environment. The company's recent financial reports indicate revenue growth, but its negative profit margin remains a concern for investors.
Looking Ahead
As Apotex Health Corp continues to implement its strategic plans, investors will be keenly watching for further developments that could impact its financial health and stock performance. The recent notes offering may provide additional capital for future growth initiatives.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
